0001209191-20-054842.txt : 20201014
0001209191-20-054842.hdr.sgml : 20201014
20201014192957
ACCESSION NUMBER: 0001209191-20-054842
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201014
FILED AS OF DATE: 20201014
DATE AS OF CHANGE: 20201014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christian Waage
CENTRAL INDEX KEY: 0001553179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38796
FILM NUMBER: 201240048
MAIL ADDRESS:
STREET 1: RECEPTOS, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gossamer Bio, Inc.
CENTRAL INDEX KEY: 0001728117
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 922-0718
MAIL ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-10-14
0
0001728117
Gossamer Bio, Inc.
GOSS
0001553179
Christian Waage
3013 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
0
1
0
0
EVP & General Counsel
Common Stock
2020-10-14
4
P
0
2500
9.5272
A
6954
I
By family trust
Common Stock
547998
D
Common Stock
22222
I
By trust FBO son
This transaction was executed in multiple trades at prices ranging from $9.52 to $9.53 per share. The price reported above reflects the
weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price
can be obtained from the Issuer upon request.
Includes 141,435 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Also includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the
terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.
/s/ Jeff Boerneke, Attorney-in-Fact
2020-10-14